Wanbury touches roof as USFDA classifies its 2 manufacturing facilities acceptable

27 Sep 2013 Evaluate

Wanbury is locked at upper circuit limit at Rs. 22.65, up by 3.75 points or 19.84% from its previous closing of Rs. 18.90 on the BSE.

The scrip opened at Rs. 20.50 and has touched a high and low of Rs. 22.65 and Rs. 19.65 respectively. So far 54,770 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 37.80 on 17-Jan-2013 and a 52 week low of Rs. 15.65 on 06-Aug-2013.

Last one week high and low of the scrip stood at Rs. 23.20 and Rs. 18.20 respectively. The current market cap of the company is Rs. 48.24 crore.

The promoters holding in the company stood at 41.36% while Institutions and Non-Institutions held 4.42% and 50.95% respectively.

Wanbury’s manufacturing facilities situated at Patalganga and Tanaku have been classified as acceptable by the Department of Health & Human Services, Public Health Service, Food and Drug Administration, USA (USFDA).

Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) and Contract Research and Manufacturing Services (CRAMS). It has a presence in Spain through its branded formulation business - Cantabria Pharma S. L acquired in 2006.

Wanbury Share Price

280.15 -3.35 (-1.18%)
23-Dec-2024 09:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.95
Dr. Reddys Lab 1339.60
Cipla 1463.70
Lupin 2129.30
Zydus Lifesciences 965.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.